Cero Therapeutics holdings sees 400,456 in stock sales by YK Bioventures - Investing.com
| 49271VAN0 | 78.55 5.91 7.00% |
About 61% of 49271VAN0's investor base is looking to short. The analysis of the overall prospects from investing in KDP 225 15 MAR 31 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 49271VAN0's historical and current headlines, can help investors time the market. In addition, many technical investors use KDP 225 15 bond news signals to limit their universe of possible portfolio assets.
49271VAN0 |
Cero Therapeutics holdings sees 400,456 in stock sales by YK Bioventures Investing.com
Read at news.google.com
 |
KDP 225 15 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 49271VAN0 bond to make a market-neutral strategy. Peer analysis of 49271VAN0 could also be used in its relative valuation, which is a method of valuing 49271VAN0 by comparing valuation metrics with similar companies.
Peers
49271VAN0 Related Equities
| ARDX | Ardelyx | 3.66 | ||||
| ALTI | Alvarium Tiedemann | 1.36 | ||||
| ALDFU | Aldel Financial | 0.20 | ||||
| RCC | Small Cap | 0.37 | ||||
| REGN | Regeneron Pharmaceuticals | 0.60 | ||||
| MS | Morgan Stanley | 0.99 | ||||
| ABCL | Abcellera Biologics | 1.32 |
Other Information on Investing in 49271VAN0 Bond
49271VAN0 financial ratios help investors to determine whether 49271VAN0 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 49271VAN0 with respect to the benefits of owning 49271VAN0 security.